BTMD

BTMD EBITDA Growth

-56.87%TTM

Period ending:

BTMD TTM EBITDA YoY %%
BTMD TTM EBITDA YoY %1312.77%-6397.58%
2022-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

BTMD ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 16 observations from Sep 30, 2022 to Jun 30, 2026.

Biote Corp Class A EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-56.8666%
-30.5404%
65.4887%
17.2585%
80.9928%
390.7038%
566.6075%
169.6732%
146.4229%
114.5736%
85.356%
-5,651.4199%
-1,252.4742%
-305.4716%
-228.886%
-102.4884%

Compare ebitda growth

All BTMD financial metrics · BTMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.